Affecting the wound healing process of chronic ulcera by an octenidine based wound antiseptic;Beeinflussung der wundheilung bei chronischen beinulzera durch ein lokales octenidin-dihydrochloridhaltiges wundantiseptikum

Hygiene + Medizin

Volumn 30, Issue 5, 2005, Pages 153-158

  Vanscheidt, W ^a   Bar M ^a   May, T W ^b   Siebert, J ^c  

^a GBP ^*  (Germany)

^b GBP   (Germany)

^c SCHÜLKE AND MAYR GMBH   (Germany)

Author keywords

Antiseptics; Chronic ulcera; Wound healing

Indexed keywords

ANTIINFECTIVE AGENT; OCTENIDINE; RINGER SOLUTION;

ADULT; AGED; ANTISEPSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FEMALE; GRANULATION TISSUE; HUMAN; LYMPHANGITIS; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; ULCER; WOUND HEALING; WOUND INFECTION;

EID: 20344397445     PISSN: 01723790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Arosio E, Ferrari G, Santoro L, Gianese F, Coccheri S: A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers. Eur J Vasc Endovasc Surg 2001; 22(4): 365-372.
2. Barrois B: Should antiseptics be used for chronic wounds? Diabetes & Metabolism 2001; 27(1): 78-81.
3. Belcaro G, Cesarone MR, Nicolaides AN, De Sanctis MT, Incandela L, Geroulakos G: Treatment of venous ulcers with pentoxifylline: a 6-month randomized, double-blind, placebo controlled trial. Angiology 2002; 53 (Suppl 1): S45-47.
4. Bowering CK: Diabetic foot ulcers. Pathophysiology, assessment, and therapy. Can. Family Physician 2001; 47: 1007-16.
5. Bulstrode CJ, Goode AW, Scott PJ: A prospective controlled trial of topical irrigation in the treatment of delayed cutaneous healing in human leg ulcers. Clin. Sci. 1988; 75 (6): 637-40.
6. Burks RI: Povidone-iodine solution in wound treatment. Physical Therapy 1998; 78 (2): 212-8.
7. Coccheri S, Scondotto G, Agnelli G, Aloisi D, Palazzini E, Zamboni V: Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers. Thromb Haemost 2002; 87 (6): 947-952.
8. Fumal I, Braham C, Paquet P, Piérard-Franchimont C, Piérard GE: The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of concept study. Dermatology 2002; 204 (suppl. 1): 70-4.
9. Hermanns JF, Paquet P, Arrese JE; Piérard-Franchimont C; Piérard GE: The beneficial cytotoxicity of antiseptics. The controversial paradox of cutaneous ulcer treatment. Revue medicale de Liège 1999; 54 (7): 600-5.
10. Goldenheim PD: An appraisal of povidone-iodine and wound healing. Postgraduate Wound Healing 1993; 69 (suppl. 3): S97-105.
11. Kallenberger A, Kallenberger C, Willenegger H: Experimentelle Untersuchungen zur Gewebeverträglichkeit von Antiseptika. Hyg Med 1991; 16: 383.
12. Kramer A, Adrian V, Rudolph P, Kühl H: In-vitro Prüfung der Verträglichkeit ausgewählter antiseptischer Wirkstoffe bzw. Präparate. In: Kramer A, Wendt M, Werner HP (Hrsg.) Möglichkeiten und Perspektiven der klinischen Antiseptik. Wiesbaden: mhp, 1995.
13. Kramer A, Roth B, Müller G, Rudolph P, Klöcker N: Influence of the Antiseptic Agents Polyhexanide and Octenidine on FL cells and on Healing of Experimental Superficial Aseptic Wounds in Piglets. Skin Pharmacol Physiol 2004; 17: 141-46.
14. Lalau JD, Bresson R, Charpentier P, Coliche V, Erlher S, Ha Van G, et al: Efficacy and tolerance of calcium alginate versus vaseline gauze dressings in the treatment of diabetic foot lesions. Diabetes Metab 2002; 28 (3): 223-229.
15. Lineaweaver W, McMorris S, Soucy D, Howard R: Cellular and bacterial toxicities of topical antimicrobials. Plastic Reconstructive Surgery 1985; 75 (3): 394-6.
16. Niedner R: Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology 1997 (suppl.); 195: 89.
17. Piérard-Franchimont C, Paquet P, Arrese JE, Piérard GE: Healing rate and bacterial necrotizing vasculitis in venous leg ulcers. Dermatology 1997; 194 (4): 383-7.
18. Pucher JJ, Daniel JC: The effects of chlorhexidine digluconate on human fibroblasts in vitro. J Periodont 1992; 63 (6): 526-32.
19. Sanchez IR, Swaim SF, Nusbaum KE, Hale AS, Henedrson RA, McGuire JA: Effects of chlorhexidine diacetate and povidone-iodine on wound healing in dogs. Veterinary Surgery 1988: 17 (6): 291-5.
20. Schmit-Neuerburg KP, Bettag C, Schlickewei W, Fabry W, Hanke J, Renzing-Köhler K, Hirche H, Kock HJ: Effectiveness of an improved antiseptic in treatment of contaminated soft tissue wounds. Der Chirurg 2001; 72 (1): 61-71.
21. Skene AI, Smith JM, Dore CJ, Charlett A, Lewis JD: Venous leg ulcers: a prognostic index to predict time to healing. BMJ 1992; 305 (6862): 1119-21.
22. Tatnall FM, Leigh IM, Gibson JR: Assay of antiseptic agents in cell culture: conditions affecting cytotoxicity. J Hosp Infect 1991; 17 (4): 287-96.
23. Tatnall FM, Leigh IM, Gibson JR: Comparative study of antiseptic toxicity on basal keratinocytes, transformed human keratinocytes and fibroblasts. Skin Pharmacol 1990; 3 (3): 157-63.